Validation and development of MTH1 inhibitors for treatment of cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation and development of MTH1 inhibitors for treatment of cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 27, Issue 12, Pages 2275-2283
Publisher
Oxford University Press (OUP)
Online
2016-11-09
DOI
10.1093/annonc/mdw429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of potent and selective MTH1 inhibitors
- (2016) Alessia Petrocchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hypoxic Signaling and the Cellular Redox Tumor Environment Determine Sensitivity to MTH1 Inhibition
- (2016) Lars Bräutigam et al. CANCER RESEARCH
- Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations
- (2016) Niels Frank Jensen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival
- (2016) Jason G. Kettle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival
- (2016) Tatsuro Kawamura et al. Scientific Reports
- Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2
- (2015) Megan Carter et al. Nature Communications
- Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
- (2015) Berglind O. Einarsdottir et al. Oncotarget
- Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
- (2014) Kilian V. M. Huber et al. NATURE
- MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
- (2014) Helge Gad et al. NATURE
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways
- (2014) A Patel et al. ONCOGENE
- Tracking cancer drugs in living cells by thermal profiling of the proteome
- (2014) M. M. Savitski et al. SCIENCE
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Human MTH3 (NUDT18) Protein Hydrolyzes Oxidized Forms of Guanosine and Deoxyguanosine Diphosphates
- (2012) Yasumitsu Takagi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More